Literature DB >> 17654572

Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain.

P Walczak1, D A Kedziorek, A A Gilad, B P Barnett, J W M Bulte.   

Abstract

LacZ-transfected C17.2 neural stem cells (NSCs) were labeled with the superparamagnetic iron oxide formulation Feridex prior to ICV injection in shi/shi neonates. Feridex labeling did not alter cell differentiation in vitro and in vivo. Initially, MR images obtained at 11.7T correlated closely to NSC distribution as assessed with anti-dextran and anti-beta-galactosidase double-fluorescent immunostaining. However, at 6 days postgrafting there was already a pronounced mismatch between the hypointense MR signal and the histologically determined cell distribution, with a surprisingly sharp cutoff rather than a gradual decrease of signal. Positive in vivo BrdU labeling of NSCs showed that significant cell replication occurred post-transplantation, causing rapid dilution of Feridex particles between mother and daughter cells toward undetectable levels. Neural differentiation experiments demonstrated asymmetric cell division, explaining the observed sharp cutoff. At later time points (2 weeks), the mismatch further increased by the presence of non-cell-associated Feridex particles resulting from active excretion or cell death. These results are a first demonstration of the inability of MRI to track rapidly dividing and self-renewing, asymmetrically dividing SCs. Therefore, MR cell tracking should only be applied for nonproliferating cells or short-term monitoring of highly-proliferative cells, with mitotic symmetry or asymmetry being important for determining its applicability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654572     DOI: 10.1002/mrm.21280

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  70 in total

1.  Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells.

Authors:  Stacey Cromer Berman; Chulani Galpoththawela; Assaf A Gilad; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2010-10-06       Impact factor: 4.668

2.  Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells.

Authors:  Yajie Liang; Piotr Walczak; Jeff W M Bulte
Journal:  J Biomed Opt       Date:  2012-01       Impact factor: 3.170

3.  Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles.

Authors:  Dorota A Kedziorek; Naser Muja; Piotr Walczak; Jesus Ruiz-Cabello; Assaf A Gilad; Chunfa C Jie; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

Review 4.  In vivo tracking of cellular therapeutics using magnetic resonance imaging.

Authors:  Christoper M Long; Jeff W M Bulte
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

5.  Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector.

Authors:  Jeong Hyun; Monica Grova; Hossein Nejadnik; David Lo; Shane Morrison; Daniel Montoro; Michael Chung; Andrew Zimmermann; Graham G Walmsley; Min Lee; Heike Daldrup-Link; Derrick C Wan; Michael T Longaker
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

6.  Epigenetics and chromatin plasticity in embryonic stem cells.

Authors:  Terézia Přikrylová; Jiří Pacherník; Stanislav Kozubek; Eva Bártová
Journal:  World J Stem Cells       Date:  2013-07-26       Impact factor: 5.326

7.  MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles.

Authors:  Assaf A Gilad; Piotr Walczak; Michael T McMahon; Hyon Bin Na; Jung Hee Lee; Kwangjin An; Taegwhan Hyeon; Peter C M van Zijl; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2008-07       Impact factor: 4.668

Review 8.  Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Authors:  Yao-Hui Tang; Yuan-Yuan Ma; Zhi-Jun Zhang; Yong-Ting Wang; Guo-Yuan Yang
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

Review 9.  Detection and quantification of magnetically labeled cells by cellular MRI.

Authors:  Wei Liu; Joseph A Frank
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

Review 10.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Authors:  Catherine Tang; Pamela J Russell; Rosetta Martiniello-Wilks; John E J Rasko; Aparajita Khatri
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.